Literature DB >> 28289855

Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Julie C Dutoit1, Koenraad L Verstraete2.   

Abstract

Magnetic resonance imaging (MRI) is the most sensitive imaging technique for the detection of bone marrow infiltration, and has therefore recently been included in the new diagnostic myeloma criteria, as proposed by the International Myeloma Working Group. Nevertheless, conventional MRI only provides anatomical information and is therefore only of limited use in the response assessment of patients with multiple myeloma. The additional information from functional MRI techniques, such as diffusion-weighted imaging and dynamic contrast-enhanced MRI, can improve the detection rate of bone marrow infiltration and the assessment of response. This can further enhance the sensitivity and specificity of MRI in the staging of multiple myeloma patients. This article provides an overview of the technical aspects of conventional and functional MRI techniques with practical recommendations. It reviews the diagnostic performance, prognostic value, and role in therapy assessment in multiple myeloma and its precursor stages.

Entities:  

Keywords:  Diffusion-weighted imaging; Dynamic contrast-enhanced MRI; MRI; Multiple myeloma

Mesh:

Substances:

Year:  2017        PMID: 28289855     DOI: 10.1007/s00256-017-2609-6

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  133 in total

Review 1.  MR imaging evaluation of the bone marrow and marrow infiltrative disorders of the lumbar spine.

Authors:  Faisal Alyas; Asif Saifuddin; David Connell
Journal:  Magn Reson Imaging Clin N Am       Date:  2007-05       Impact factor: 2.266

Review 2.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

3.  Inversion recovery snapshot FLASH MR imaging.

Authors:  A Haase; D Matthaei; R Bartkowski; E Dühmke; D Leibfritz
Journal:  J Comput Assist Tomogr       Date:  1989 Nov-Dec       Impact factor: 1.826

Review 4.  Advances in imaging and the management of myeloma bone disease.

Authors:  Evangelos Terpos; Lia A Moulopoulos; Meletios A Dimopoulos
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

5.  Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome.

Authors:  B C Vande Berg; L Michaux; F E Lecouvet; M Labaisse; J Malghem; J Jamart; B E Maldague; A Ferrant; J L Michaux
Journal:  Radiology       Date:  1997-01       Impact factor: 11.105

6.  Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.

Authors:  Anwar R Padhani; Katherine van Ree; David J Collins; Shirley D'Sa; Andreas Makris
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

7.  Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

Authors:  Andrea Baur-Melnyk; Sonja Buhmann; Christoph Becker; Stefan Oswald Schoenberg; Nicola Lang; Reiner Bartl; Maximilian Ferdinand Reiser
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

8.  Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease.

Authors:  P Spinnato; A Bazzocchi; A Brioli; C Nanni; E Zamagni; U Albisinni; M Cavo; S Fanti; G Battista; E Salizzoni
Journal:  Eur J Radiol       Date:  2012-08-24       Impact factor: 3.528

9.  Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance.

Authors:  Z Adam; K Bolcak; J Stanicek; T Buchler; L Pour; M Krejci; J Prasek; J Neubauer; J Vorlicek; R Hajek
Journal:  Neoplasma       Date:  2007       Impact factor: 2.575

10.  Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.

Authors:  Julie C Dutoit; Matthias A Vanderkerken; Koenraad L Verstraete
Journal:  Eur J Radiol       Date:  2013-05-28       Impact factor: 3.528

View more
  9 in total

1.  Skeletal Radiology: The Year in Review 2017.

Authors:  Daniel I Rosenthal; Mark J Kransdorf; Thomas M Link; Gunnar Astrom
Journal:  Skeletal Radiol       Date:  2018-03       Impact factor: 2.199

Review 2.  Whole body imaging in musculoskeletal oncology: when, why, and how.

Authors:  Joao R T Vicentini; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2022-07-09       Impact factor: 2.199

Review 3.  Advanced Imaging of Multiple Myeloma Bone Disease.

Authors:  Barry G Hansford; Rebecca Silbermann
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-07       Impact factor: 5.555

4.  Whole body MRI in multiple myeloma: Optimising image acquisition and read times.

Authors:  Saurabh Singh; Elly Pilavachi; Alexandra Dudek; Timothy J P Bray; Arash Latifoltojar; Kannan Rajesparan; Shonit Punwani; Margaret A Hall-Craggs
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

Review 5.  Imaging for Plasma Cell Dyscrasias: What, When, and How?

Authors:  Amrita Guha; Antariksh Vijan; Ujjwal Agarwal; Jayant Sastri Goda; Abhishek Mahajan; Nitin Shetty; Navin Khattry
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

6.  Feasibility of artificial intelligence-supported assessment of bone marrow infiltration using dual-energy computed tomography in patients with evidence of monoclonal protein - a retrospective observational study.

Authors:  Philipp Fervers; Florian Fervers; Jonathan Kottlors; Philipp Lohneis; Philip Pollman-Schweckhorst; Hasan Zaytoun; Miriam Rinneburger; David Maintz; Nils Große Hokamp
Journal:  Eur Radiol       Date:  2021-12-18       Impact factor: 7.034

7.  Case report: Thoracic and lumbar plasma cell myeloma mimicking hemangiomas on MRI and 18F-FDG PET/CT.

Authors:  Xianwen Hu; Wei Xiong; Shun Li; Xue Li; Jiong Cai; Pan Wang; Dandan Li
Journal:  Front Med (Lausanne)       Date:  2022-08-04

8.  Whole-body diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma.

Authors:  Dan Costachescu; Ioana Ionita; Ema-Cristina Borsi; Ovidiu Potre; Cristina Potre; Dan-Bogdan Navolan; Alexandru Blidisel; Hortensia Ionita; Adelina Erimescu; Gheorghe Nicusor Pop; Daniel Claudiu Malita
Journal:  Exp Ther Med       Date:  2021-06-03       Impact factor: 2.447

Review 9.  Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging.

Authors:  Karla M Treitl; Jens Ricke; Andrea Baur-Melnyk
Journal:  Skeletal Radiol       Date:  2021-05-24       Impact factor: 2.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.